« Previous
Next »
Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 2
, Pages 79-81
, June 2009
A brief history of photodynamic therapy in Wrocław
References
- . 5,20-bis(4-sulphophenyl)-10,15-bis(2-methoxy-4-sulphophenyl)-21-thiaporphyrin as a new potent sensitizer in photodynamic therapy. Tumori. 1995;81:364–369
- . In-vivo interleukin-1-alpha induction following chlorin e6-photodynamic therapy in Balb/c mice. Proc SPIE. 1996;2625:426–433
- . In vivo tumor necrosis factor-alpha induction following chlorin e6-photodynamic therapy in Buffalo rats. Neoplasma. 1997;44:192–196
- . The new sensitizing agents for photodynamic therapy: 21-selenaporphyrin and 21-thiaporphyrin. Anticancer Res. 1997;17:3313–3320
- . Tumor histopathology following new sensitizers: dithiaporphyrin- and sulfoxaporphyrin-mediated photodynamic therapy. Anticancer Res. 1999;19:5385–5392
- . Photodynamic treatment of epithelial tissue derived from patients with endometrial cancer. A contribution to the role of laminin and epidermal growth factor receptor in photodynamic therapy. J Biomed Opt. 1999;4:272–275
- . New sensitizers for photodynamic therapy. The comparison of monothia-, dithia- and sulfoxaporphyrins. J Cancer Res Clin Oncol. 1999;125:563–568
- . The combined treatment of transplantable solid mammary carcinoma in Wistar rats by use of photodynamic therapy and cysteine proteinase inhibitor. In Vivo. 2001;15:351–358
- . Local photodynamic therapy of actinic keratosis with 5-aminolevulinic acid. Acta Bio-optica Inform Med. 2002;8:215–217
- . Determination of Vascular-Endothelial Growth Factor levels in serum from tumor-bearing BALB/c mice treated with photodynamic therapy. Med Sci Monit. 2003;9:110–114
- . Determination of basic-Fibroblast Growth Factor levels in serum from tumor-bearing BALB/c mice treated with photodynamic therapy. Pol J Pathol. 2003;54:117–121
- . In vitro human atherosclerotic plaque recognition by photosensitizer mono-l-aspartyl-chlorin e6 assisted Light Induced Fluorescence (PALIF). Proc SPIE. 2003;5229:127–131
- . Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol. 2004;4:121–129
- . Photodynamic therapy in the treatment of the oral leukoplakia—preliminary report. Dent Med Probl. 2004;41:225–228
- . Pretreatment of plantar warts with azone enhances the effect of 5-amino levulinic acid-photodynamic therapy. J Environ Pathol Toxicol Oncol. 2006;25:403–409
- . Evaluation of immobilized photosensitizers in terms of photodynamic therapy on Morris hepatoma cells. Dent Med Probl. 2006;43:175–180
- . Photodynamic therapy combined with a cysteine protease inhibitor synergistically decrease VEGF production and promote tumor necrosis in rat mammary carcinoma. Cell Prolif. 2006;40:38–49
- . Photofrin II-based photosensitization of human ovarian clear-cell carcinoma cell line (OvBH-1). Pharmacol. Rep. 2007;59:150–160
- . Application of photodynamic therapy in the sterilisation of tumour cells transplanted into laboratory animals. Bull Vet Inst Pulawy. 2009;53:123–128
- . Photodynamic therapy as an alternative treatment method of multifocal oral leukoplakia. Pol J Environ Stud. 2009;18(1A):634–638
PII: S1572-1000(09)00063-5
doi: 10.1016/j.pdpdt.2009.07.004
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 2
, Pages 79-81
, June 2009
